Skip to main content
Neurology® Neuroimmunology & Neuroinflammation logoLink to Neurology® Neuroimmunology & Neuroinflammation
. 2024 Mar 19;11(3):e200246. doi: 10.1212/NXI.0000000000200246

Complement Activation Is Associated With Disease Severity in Multiple Sclerosis

PMCID: PMC10959166  PMID: 38507658

In the Research Article “Complement Activation Is Associated With Disease Severity in Multiple Sclerosis” by Oechtering et al.,1 the 29th author's name should be listed as “Jan D. Lunemann, MD.” The article has been replaced by a corrected version. The authors regret the error.

Reference

  • 1.Oechtering J, Stein K, Schaedelin SA, et al. Complement activation is associated with disease severity in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2024;11(2):e200212. doi: 10.1212/NXI.0000000000200212 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology® Neuroimmunology & Neuroinflammation are provided here courtesy of American Academy of Neurology

RESOURCES